Page 17 - Recognizing axial spondyloarthritis - Janneke de Winter

26. Boonen A, Sieper J, Heijde D van der, Dougados M, Bukowski JF, Valluri S, et al. The burden of non- radiographic axial spondyloarthritis. Semin Arthritis Rheum 2015;44:556– 562.
27. Zhang JR, Liu XJ, Xu WD, Dai SM. Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis. Jt Bone Spine 2016;83:257–264.
28. Dougados M, Heijde D van der, Sieper J, Braun J, Citera G, Lenaerts J, et al. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo- Controlled Study. Arthritis Care Res 2017;69:1590–1598.
29. Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89–95.
30. Berg R van den, Hooge M de, Gaalen F van, Reijnierse M, Huizinga T, Heijde D van der. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 2013;52:1492–9.
31. Blachier M, Canouï-Poitrine F, Dougados M, Lethuaut A, Fautrel B, Ferkal S, et al. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort. Rheumatology (Oxford) 2013;52:1686–93.
32. Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005;64:1462–1466.
33. Turina MC, Yeremenko N, Gaalen F Van, Oosterhout M Van, Berg IJ, Ramonda R, et al. Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: Results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open 2017;3.
34. Baraliakos X, Baerlecken N, Witte T, Heldmann F, Braun J. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Ann Rheum Dis 2013:1–5.
35. Baerlecken NT, Nothdorft S, Stummvoll GH, Sieper J, Rudwaleit M, Reuter S, et al. Autoantibodies against CD74 in spondyloarthritis. Ann Rheum Dis 2014;73:1211–4.
36. Robinson PC, Brown M a. Genetics of ankylosing spondylitis. Mol Immunol 2014;57:2–11.
37. Reveille JD. Genetics of spondyloarthritis--beyond the MHC. Nat Rev Rheumatol 2012;8:296–304.
38. Schlosstein L, Terasaki P, Bluestone R, Pearson C. High association of an HL-A antigen, W27, with ankylosing spondylitis. New English J Med 1973:704–6.
39. Sims A-M, Wordsworth BP, Brown MA. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 2004;4:13–20.
GENERAL INTRODUCTION AND OUTLINE
15
ONE